Concepedia

Stewart A. Turner

SA

Statistics

Publications

20

Citations

4K

H-Index

18

Active since

1997

Affiliations

Amgen (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Arena Pharmaceuticals (United States)

University of California, Los Angeles

Stewart A. Turner is an author at Amgen (United States) specializing in medicine, pharmacotherapy, and parathyroid disorders.

Publications per year

1997–2023

20

Publications

20

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Geoffrey A. Block, Kévin Martin, Ángel Francisco et al. · New England Journal of Medicine · 2004 · 1.1K citations

, , +17

Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism

Munro Peacock, John P. Bilezikian, Preston Klassen et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 464 citations · Full text

, , +17

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl

Sharon M. Moe, Glenn M. Chertow, Jack W. Coburn et al. · Kidney International · 2005 · 330 citations

, , +12

The Calcimimetic Agent AMG 073 Lowers Plasma Parathyroid Hormone Levels in Hemodialysis Patients with Secondary Hyperparathyroidism

William G. Goodman, Gerald A. Hladik, Stewart A. Turner et al. · Journal of the American Society of Nephrology · 2002 · 280 citations

, , +16

The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism

Dolores Shoback, John P. Bilezikian, Stewart A. Turner et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 250 citations · Full text

, , +17

1–5 of 20